A phase II clinical trial of echinomycin in metastatic soft tissue sarcoma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Corbaz R, Ettinger L, Gaumann E, Keller-Schierlein W, Kradolfer S, Neipp L, Prelog V, Reusser P, Zahner H: Metabolic products of actinomycetes. VII. Echinomycin. Helv Chim Acta 40:199–204, 1957
Martin DG, Misak SA, Biles C, Stewart JC, Baczynskyj L, Meulmann PA: Structure of quinomycin antibiotics. J Antibiot 28:332–336, 1975
Ward DC, Reich E, Goldberg IH: Base specificity in the interaction of polynucleotides with antibiotic drugs. Science 149:1259–1263, 1965
Wakelin LPG, Waring MJ: The binding of echinomycin to deoxyribonucleic acid. Biochem J 157:721–740, 1976
Lathan B, Von Hoff DD: Cytotoxin activity of echinomycin in a human tumor cloning system. Cancer Drug Delivery 1:191–198, 1984
Kuhn J, Von Hoff D, Hersh M: Phase I trial of echinomycin (NSC-526417), a bifunctional intercalating agent, administered by 24 hour continuous infusion. Eur J Cancer Clin Oncol 25:797–803, 1989
Pazdur R, Haas CD, Baker LH, Leichman CG, Decker D: Phase I study of echinomycin. Cancer Treat Rep 71:117–119, 1987
Harvey JH, McFadden M, Andrews WG, Byre PJ: Phase I study of echinomycin administered on an intermittent bolus schedule. Cancer Treat Rep 69:1365–1368, 1985
Antman KH: Sarcoma of bone and soft tissue. In: Perry MC (ed). The Chemotherapy Sourcebook. Baltimore, Williams and Wilkins, pp. 1068–1093, 1992
Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47:207–214, 1981
Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481, 1958
Shevrin DH, Lad TE, Guinan P, Kilton LJ: Phase II trial of echinomycin in advanced hormone-resistant prostate cancer. An Illinois Cancer Council study. Invest New Drugs 12:65–66, 1994